Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

3(50.0%)

N/A

2(33.3%)

Phase 2

1(16.7%)

6Total

Phase 3(3)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04534660Not ApplicableCompleted

Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler

Role: collaborator

NCT04029545Phase 3Terminated

A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation

Role: collaborator

NCT04029519Phase 3Completed

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Role: collaborator

NCT04032977Completed

Safety and Effectiveness of PN40082 for Lip Augmentation

Role: collaborator

NCT04088357Phase 2Completed

Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants

Role: collaborator

NCT03072550Not ApplicableCompleted

Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail)

Role: collaborator

NCT01650051Phase 3Completed

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Role: collaborator

All 7 trials loaded